| Title： | A Rapid Advice Guideline of Traditional Chinese Medicine for Diagnosis and Treatment of Corona Virus Disease 2019 (COVID-19) |
| Edition： | Updated |
| Classification： | Rapid advice guideline |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | The worldwide medical workers who are taking care of people with COVID-19 from such as fever clinics, emergency departments, critical care departments, respiratory departments, traditional Chinese medicine departments, and integrative tradtional Chinese a |
| Evidence classification method： | 采用GRADE系统对证据体质量进行评价和分级。基于RCT的系统评价起始质量为高，考虑五个降级因素：偏倚风险、间接性、异质性、不精确性、发表偏倚；而基于观察性研究的起始质量为低，考虑大效应量、剂量-效应关系和负偏倚三个升级因素，最后分为高、中、低、极低四个证据等级，以证据总结表形式呈现。 |
| Development unit： | China Center for Evidence-Based Traditional Chinese Medicine Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences |
| Registration time: | 2020-03-09 |
| Registration number： | IPGRP-2020CN033 |
| Purpose of the guideline: | To develop a patient-oriented evidence-based rapid advice guideline assisting the clinical practice of traditional Chinese medicine (TCM) for COVID-19, as well as enhancing the ability to cope with the disease, and improving the application and influence |
